Pharmaceutical companies Merck & Co, Eli Lilly, and Amgen are suing the US Department of Health and Human Services over proposed rules which would force companies to disclose the list prices of drugs in TV advertisements.
US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
US biopharmaceutical company Pfizer has entered agreed to acquire Array BioPharma, a biotechnology company which develops small molecule drugs for the treatment of cancer.
The US Food and Drug Administration has chosen Merck & Co, IBM, KPMG, and Walmart to form a pilot project aimed at evaluating the use of blockchain to protect pharmaceutical product integrity.
British-based pharmaceutical company GSK has entered into a five-year collaboration with the University of California to explore how gene mutations cause disease and accelerate drug discovery.
Software company Dassault Systèmes has targeted the life sciences sector with the $5.8 billion acquisition of Medidata Solutions, a US-firm firm focused on clinical trials.
BASF Plant Science, the plant biotech-focused subsidiary of BASF, has asked the US Court of Appeals for the Federal Circuit to overturn a finding that certain claims of a transgenic plant technology patent were invalid.
A Russian scientist is planning to create CRISPR-edited babies, despite the widespread condemnation levelled at the first scientist who created ‘edited’ twins.
Dominican Republic-based Agroindustrial Ocoeña has asked a US court to dismiss its plant patent claim against a competitor run by the patent inventor’s brother.
India is to make barcoding mandatory on all medicines sold within the country after a recent report by the Office of the US Trade Representative (USTR) identified the country as the largest producer of counterfeit pharmaceuticals in the world.